Browse studies

Find your next paid study

15 recruiting studies matching your filters

A Randomized, Double-Blind, Two-Part, Placebo-Controlled, Multicenter, Phase 2a Study to Evaluate Safety, Tolerability, and Efficacy of INNA-051 as Prophylaxis for Respiratory Tract Illness in Healthy Adults 18 to 45 Years of Age Who Are at Risk for Viral Respiratory Infections

Acute upper and lower respiratory infections are a major public health problem and a leading cause of morbidity and mortality worldwide. The purpose of this tr…

Viral Respiratory InfectionViral Respiratory Illnesses

Estimated

~$10 – $8,750

ENA Respiratory Pty LtdNCT07222670

Estimating the Risk for and Severity of Respiratory Infections Attributable to CFTR Heterozygosity

A research team member will brush the inferior surface of the subjects' middle turbinate (nasal cavity) using a cytology brush to obtain the cells needed to pe…

Carrier StateRespiratory Infections

Estimated

~$10 – $1,125

Philip PolgreenNCT05474430

Phase 1

Development and Evaluation of a Host Pathologic State-Directed Botanical Therapeutic Platform Technology for Acute Viral Respiratory Infection

This Phase 1 study will evaluate the feasibility and safety of implementing a host pathologic state-directed botanical therapeutic platform in adults with acut…

Acute Viral Respiratory Infection

Estimated

~$10 – $6,250

All Natural Medicine Clinic, LLCNCT07805447

FebriDx® Pediatric Validation Study Protocol

The primary objective of this study is to determine performance characteristics of the FebriDx® test in differentiating bacterial from non-bacterial etiology a…

Acute Respiratory Infections (ARIs)

Estimated

~$10 – $1,050

Lumos DiagnosticsNCT07211997

Assessment of Functional Impact of Acute Respiratory Viral Infections in Older Adults - An International Multi-center Study

The prevention of infectious diseases in older adults remains a major public health challenge, as acute respiratory infections are a leading cause of hospitali…

Respiratory Infections in Old Age

Estimated

~$10 – $750

University Hospital, GrenobleNCT07388173

Cardiac Magnetic Resonance for Tissue Characterization-Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors

The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of c…

COVID-19 PneumoniaCOVID-19COVID-19 Respiratory Infection+4 more

Estimated

~$10 – $750

Weill Medical College of Cornell UniversityNCT05164744

Phase 1

A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b/2a Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus® Nebulizer in Subjects With Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung Infection

A double-blind, active-controlled, multiple-ascending dose, safety study of aerosolized RSP-1502 in subjects with cystic fibrosis Pseudomonas aeruginosa lung i…

Cystic Fibrosis LungRespiratory Infections, Recurrent, ChronicPseudomonas Aeruginosa

Estimated

~$10 – $8,750

Respirion Pharmaceuticals Pty LtdNCT06016088

PREVENT: Preparedness Through Respiratory Virus Epidemiology and Community Engagement

The CHARM network will be established through three primary institutions-Beth Israel Deaconess Medical Center (BIDMC), the University of California San Diego (…

Respiratory Infection VirusCOVID -19RSV+1 more

Estimated

~$10 – $750

University of California, San DiegoNCT07147517

Phase 2

Omalizumab Before Onset of Exacerbations

OBOE is a prospective, pilot, parallel group RCT with the overall aim of examining the effect of a single dose of anti-IgE (omalizumab) vs. placebo administere…

Asthma in ChildrenAtopyViral Upper Respiratory Infection

Estimated

~$10 – $5,625

Children's National Research InstituteNCT05332067

Observational

Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial

This research study will use a hybrid effectiveness-implementation type 1 design to assess effectiveness of the Spotfire R/ST assay in the urgent care setting.…

Acute Respiratory Infections (ARIs)

Estimated

~$10 – $7,500

BioMérieuxNCT07513519

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel - Sponsor's Protocol

The Biomedical Advanced Research and Development Authority (BARDA) has contracted BioFire Defense (BFDf) to develop the BioFire Emerging Coronavirus (ECoV) Pan…

CoronavirusRespiratory InfectionCOVID

Estimated

~$10 – $1,050

BioFire Defense LLCNCT07221097

Observational

ORegon CHild Absenteeism Due to Respiratory Disease Study - Air Surveillance

The purpose of this observational study is to compare the effectiveness of air surveillance and to better understand the relationship between household transmi…

Acute Respiratory InfectionInfluenza-like Illness

Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT07298967